| #60 |
Markus Rösch |
Basf Se |
1 |
| #60 |
Rolf Kuenzi |
Dsm Ip Assets B.V. |
1 |
| #60 |
Laszlo Fekete |
Ciba Specialty Chemicals |
1 |
| #60 |
Sophie Laurenson |
Abbott |
1 |
| #60 |
Dembic Zlatko |
Hoffmann-La Roche |
1 |
| #60 |
Christine Binswanger |
— |
1 |
| #60 |
Jacob Andreas Leuenberger |
Syngenta Crop Protection Ag |
1 |
| #60 |
Jacques Chollet |
Medicines For Malaria Venture |
1 |
| #60 |
Daniel Schwizer |
Glycomimetics |
1 |
| #60 |
Adrian Alberto Friedmann |
Syngenta Crop Protection Ag |
1 |
| #60 |
Miro Venturi |
Bayer Technology Services Gmbh |
1 |
| #60 |
Jan Barnikow |
Ecole Polytechnique Federale De Lausanne (Epfl) |
1 |
| #60 |
Marco Tamborrini |
Eth Zurich |
1 |
| #60 |
Anja Meury |
Dsm Ip Assets B.V. |
1 |
| #60 |
Ruediger Wilz |
Kpss-Kao Professional Salon Services Gmbh |
1 |
| #60 |
Dominique Grimler |
Novartis Ag |
1 |
| #60 |
Stefan Martin Stoeckli |
Dsm Ip Assets B.V. |
1 |
| #60 |
Aaldert Molenberg |
Straumann Holding Ag |
1 |
| #60 |
Eric Billy |
Novartis Ag |
1 |
| #60 |
Stephen Paboojian |
Novartis Ag |
1 |
| #60 |
Philip Huxley |
British Biotech Pharmaceuticals |
1 |
| #60 |
Rosa Maria Rodriguez Sarmiento |
— |
1 |
| #60 |
Christoph Max Krell |
Novartis Ag |
1 |
| #60 |
Francois Jean-Charles Natt |
Novartis Ag |
1 |
| #60 |
Robert Alexander Pulz |
Novartis Ag |
1 |
| #60 |
Andreas Boudier |
Acadia Pharmaceuticals |
1 |
| #60 |
Michaela Kneissel |
Novartis Ag |
1 |
| #60 |
Markus Zweili |
Hammerle Ag |
1 |